STERIS’ (TSE:STE – Get Free Report) was upgraded by analysts at Atb Cap Markets to a “strong-buy” rating in a report issued on Sunday,Zacks.com reports.
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Read More
- Five stocks we like better than STERIS’
- NYSE Stocks Give Investors a Variety of Quality Options
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- EV Stocks and How to Profit from Them
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
